- Centers & Specialties
- Clinical Interests
- Familial hypercholesterolemia
- Preventive cardiology
- Cardiovascular genetics
- Coronary artery disease
- Lipid disorders
- Medical Education
- MD, University of Pennsylvania School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Internal Medicine
- Cardiovascular Disease
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
Dr. Khera received his BS in Biology and Neurosciences from Duke University in 2005, graduating summa cum laude. He received his MD with Alpha Omega Alpha honors from the Perelman School of Medicine at the University of Pennsylvania in 2010. He completed his internship and residency in internal medicine at the Brigham and Women's Hospital, Harvard Medical School in 2013. He completed his clinical and research fellowship in cardiovascular medicine at the Massachusetts General Hospital, Harvard Medical School in 2016.
Dr. Khera is a physician-scientist with expertise in epidemiology, clinical medicine, and human genetics. Among his scientific contributions, he pioneered a new approach to quantify genetic risk for common diseases, developed biomarkers that provide new biologic insights, and analyzed large-scale gene sequencing data to highlight key pathways underlying risk for coronary artery disease. His research program uses genetic variation as a tool to uncover new biology and enable enhanced clinical care informed by inherited susceptibility.
In addition to his research efforts, Dr. Khera is a clinical cardiologist within the Corrigan Minehan Heart Center focusing on heart attack prevention, genomic medicine, and cardiac rehabilitation.
- Khera AV, Won HH, Peloso GM, et al. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol. 2016;67(22):2578-89.
- Khera AV, Everett BM, Caulfield MP, et al. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). Circulation. 2014;11;129(6):635-42.
- Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011;364(2):127-35.
Researchers at Massachusetts General Hospital, armed with an unprecedented amount of genetic data, are developing polygenic scores to more accurately predicting disease, including cardiovascular disease risk
Two recent studies expand practitioners’ tool kits during a consult by providing patients with two action steps to help manage risk of premature death from heart disease
Precision medicine can help answer whether or not current heart disease treatment paradigms optimally address genetic heterogeneity.
25 New Chardon Street
Boston, MA 02114-4774